Stem cells have potent potential for diabetes treatment
medicalxpress - Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into any cell type makes them pluri…
AI Summary: Researchers report stem cell–based approaches can replenish insulin‑producing cells and restore glycemic control in diabetes models, offering a potential path beyond daily insulin injections. Early findings suggest significant therapeutic promise, but scientists stress that safety, durability, and immune‑rejection hurdles must be cleared before these techniques graduate from experimental hope to standard care.
Related Stories
First-in-human trial primes immune system to accept donor livers / 2 months
Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 2 months
Ten‑year follow‑up shows durable remissions with CD19 CAR‑T therapy / 14 days
Single‑infusion gene editing dramatically lowers LDL cholesterol in early trial / 5 wks
FDA clears first once‑weekly basal insulin for Type 2 diabetes / 3 months
Drug-induced hibernation shows promise to limit stroke brain injury / 21 days
BioMarin Phase 3 failure dims hopes for rare‑disease therapy / 7 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Genetics, None, Diagnostics, Mergers and Acquisitions and look for the RSS link.
StackHealth Time Machine